Sabi Salsabeel H, Alzreqat Roaa K, Almaaytah Ammar M, Masaadeh Majed M, Abualhaijaa Ahmad Khaled
Basic Sciences Department, The Hashemite University, Zarqa, Jordan.
Department of Biological Sciences, The Hashemite University, Zarqa, Jordan.
Diabetes Metab Syndr Obes. 2024 Nov 26;17:4439-4452. doi: 10.2147/DMSO.S482056. eCollection 2024.
Hyperinsulinemic Hypoglycemia (HH) is a rare condition that affects newborn children in the postnatal period, represented by dangerously low levels of blood glucose in a persistent manner, which puts the baby at high risk of multiple issues, especially regarding the brain cells if the baby does not take the appropriate medication or have the correct diagnosis. Hyperinsulinemic Hypoglycemia can happen due to an active or inactive mutation in 16 genes responsible for glucose metabolism and insulin secretion (, , , , , , , , , , , , , , , ). These mutations can take place in many forms, either defused or local, affecting several or all pancreatic beta cells respectively. This review summarizes genetic variations diagnosis and treatment of Hyperinsulinemic Hypoglycemia.
高胰岛素血症性低血糖症(HH)是一种罕见的病症,会在出生后影响新生儿,其特征是血糖水平持续处于危险的低水平,这使婴儿面临多种问题的高风险,尤其是如果婴儿未接受适当治疗或未得到正确诊断,对脑细胞的影响更大。高胰岛素血症性低血糖症可能是由于16个负责葡萄糖代谢和胰岛素分泌的基因发生了活性或非活性突变(,,,,,,,,,,,,,,,)。这些突变可以有多种形式,要么是分散的,要么是局部的,分别影响几个或所有胰腺β细胞。本综述总结了高胰岛素血症性低血糖症的基因变异、诊断和治疗。